CMV antiviral may reduce inflammation and improve immune function in people with HIV
Letermovir, an antiviral drug for cytomegalovirus (CMV), was associated with reduced inflammation, improved CD4/CD8 T-cell ratios and better physical function...
HIV
Duke Team Identifies a Strategy to Guide the Immune System to Respond to HIV
Contact DURHAM, N.C. – Highly specific HIV antibodies could be induced by vaccination using a new strategy developed by researchers...
